Epidermal growth factor receptor as a biomarker for cervical cancer
Soonthornthum, T., Arias-Pulido, H., Joste, N., Lomo, L., Muller, C., Rutledge, T., Verschraegen, C.
Published in Annals of oncology (01.10.2011)
Published in Annals of oncology (01.10.2011)
Get full text
Journal Article
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
O'Day, S.J., Maio, M., Chiarion-Sileni, V., Gajewski, T.F., Pehamberger, H., Bondarenko, I.N., Queirolo, P., Lundgren, L., Mikhailov, S., Roman, L., Verschraegen, C., Humphrey, R., Ibrahim, R., de Pril, V., Hoos, A., Wolchok, J.D.
Published in Annals of oncology (01.08.2010)
Published in Annals of oncology (01.08.2010)
Get full text
Journal Article
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer
Verschraegen, C.F., Czok, S., Muller, C.Y., Boyd, L., Lee, S.J., Rutledge, T., Blank, S., Pothuri, B., Eberhardt, S., Muggia, F.
Published in Annals of oncology (01.12.2012)
Published in Annals of oncology (01.12.2012)
Get full text
Journal Article
Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer
Ades, S., Kumar, S., Alam, M., Goodwin, A., Weckstein, D., Dugan, M., Ashikaga, T., Evans, M., Verschraegen, C., Holmes, C. E.
Published in Journal of thrombosis and haemostasis (01.06.2015)
Published in Journal of thrombosis and haemostasis (01.06.2015)
Get full text
Journal Article
Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen
Verschraegen, C.F., Arias-Pulido, H., Lee, S.-J., Movva, S., Cerilli, L.A., Eberhardt, S., Schmit, B., Quinn, R., Muller, C.Y., Rabinowitz, I., Purdy, M., Snyder, D., Bocklage, T.
Published in Annals of oncology (01.03.2012)
Published in Annals of oncology (01.03.2012)
Get full text
Journal Article
Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim
Moukharskaya, J., Abrams, D. M., Ashikaga, T., Khan, F., Schwartz, J., Wilson, K., Verschraegen, C., Openshaw, T., Valentine, J., Eneman, J., Unger, P., Ades, S.
Published in Supportive care in cancer (01.07.2016)
Published in Supportive care in cancer (01.07.2016)
Get full text
Journal Article
Immune related adverse events across cancer types: Incidence, risk factors and survival
Owen, D.H., Burkart, J., Patel, S., Wei, L., Tinoco, G., Liebner, D., He, K., Shields, P.G., Bertino, E.M., Presley, C.J., Johns, A., Folefac, E., Olencki, T., Carbone, D.P., Verschraegen, C., Otterson, G.A., Kendra, K.L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference
Hassan, R, Alexander, R, Antman, K, Boffetta, P, Churg, A, Coit, D, Hausner, P, Kennedy, R, Kindler, H, Metintas, M, Mutti, L, Onda, M, Pass, H, Premkumar, A, Roggli, V, Sterman, D, Sugarbaker, P, Taub, R, Verschraegen, C
Published in Annals of oncology (01.11.2006)
Published in Annals of oncology (01.11.2006)
Get full text
Journal Article
Conference Proceeding
GnRH antagonists in the treatment of gynecological and breast cancers
Emons, G, Gründker, C, Günthert, A R, Westphalen, S, Kavanagh, J, Verschraegen, C
Published in Endocrine-related cancer (01.06.2003)
Published in Endocrine-related cancer (01.06.2003)
Get full text
Journal Article
Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer
MCMEEKIN, S, PATEL, R, SCHMELTER, T, VERSCHRAEGEN, C, CELANO, P, BURKE, J, PLAXE, S, GHATAGE, P, GIURESCU, M, STREDDER, C, WANG, Y
Published in British journal of cancer (03.01.2012)
Published in British journal of cancer (03.01.2012)
Get full text
Journal Article
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer
Vadhan-Raj, S, Verschraegen, C F, Bueso-Ramos, C, Broxmeyer, H E, Kudelkà, A P, Freedman, R S, Edwards, C L, Gershenson, D, Jones, D, Ashby, M, Kavanagh, J J
Published in Annals of internal medicine (07.03.2000)
Published in Annals of internal medicine (07.03.2000)
Get more information
Journal Article
Absence of epidermal growth factor receptor mutations in cervical cancer
Arias-Pulido, H, Joste, N, Chavez, A, Muller, C Y, Dai, D, Smith, H O, Verschraegen, C F
Published in International journal of gynecological cancer (01.07.2008)
Published in International journal of gynecological cancer (01.07.2008)
Get more information
Journal Article
Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470
Kudelka, Andrzej P, Verschraegen, Claire F, Loyer, Evelyn
Published in The New England journal of medicine (02.04.1998)
Published in The New England journal of medicine (02.04.1998)
Get full text
Journal Article
Docetaxel for Patients With Paclitaxel-Resistant Müllerian Carcinoma
Verschraegen, C F, Sittisomwong, T, Kudelka, A P, Guedes, E d, Steger, M, Nelson-Taylor, T, Vincent, M, Rogers, R, Atkinson, E N, Kavanagh, J J
Published in Journal of clinical oncology (01.07.2000)
Published in Journal of clinical oncology (01.07.2000)
Get full text
Journal Article
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix
Verschraegen, C F, Levy, T, Kudelka, A P, Llerena, E, Ende, K, Freedman, R S, Edwards, C L, Hord, M, Steger, M, Kaplan, A L, Kieback, D, Fishman, A, Kavanagh, J J
Published in Journal of clinical oncology (01.02.1997)
Published in Journal of clinical oncology (01.02.1997)
Get more information
Journal Article
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma
Kudelka, A P, Tresukosol, D, Edwards, C L, Freedman, R S, Levenback, C, Chantarawiroj, P, Gonzalez de Leon, C, Kim, E E, Madden, T, Wallin, B, Hord, M, Verschraegen, C, Raber, M, Kavanagh, J J
Published in Journal of clinical oncology (01.05.1996)
Published in Journal of clinical oncology (01.05.1996)
Get more information
Journal Article
Pegylated liposomal doxorubicin with bevacizumab in the treatment of platinum-resistant ovarian cancer: Toxicity profile results
Czok, S, Jewell, A, Shawki, S, Boyd, L, Smith, H, Blank, S, Muller, C, Verschraegen, C, Muggia, F
Published in Gynecologic oncology (01.03.2011)
Published in Gynecologic oncology (01.03.2011)
Get full text
Journal Article
Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors
Hu, W, McCrea, P D, Deavers, M, Kavanagh, J J, Kudelka, A P, Verschraegen, C F
Published in Clinical & experimental metastasis (2000)
Published in Clinical & experimental metastasis (2000)
Get full text
Journal Article